Free Review Articles on Everolimus                                 Metatextbook

Freie Reviews über Everolimus                                 Look here for Journal Homepages

  • Everolimus
  • Leukemia (chronic lymphatic)
  • Lymphoma (BASKET)
  • MTOR
  • Protein kinase C beta
  • Temsirolimus
  • Syk
  • Lymphoma (B cell diffuse large)
  • Enzastaurin
  • Fostamatinib
  • Kidney (Neoplasm)
  • Sunitinib
  • Bevacizumab
  • Sorafenib
  • Pazopanib
  • Rapamycin
  • CCI779
  • AP23573
  • Tuberous sclerosis
    • Nr.Year

    OPEN

    		Titleusers

    say

    		rate

    good

    		rate

    bad

    no link

    		Citation
    12010Biomarker Development for the Clinical Activity of the mTOR Inhibitor Everolimus (RAD001): Processes, Limitations, and Further Proposals.



    		+-nlTransl Oncol 3(2):65-79 (2010)
    22006Everolimus in clinical practice--renal transplantation.



    		+-nlNephrol Dial Transplant 21 Suppl 3(-):iii18-23 (2006)
    32010Signal transduction inhibitor therapy for lymphoma.



    		+-nlHematology Am Soc Hematol Educ Program 2010(-):265-70 (2010)
    42010Targeted therapy for renal cell cancer: current perspectives.



    		+-nlDiscov Med 10(54):394-405 (2010)
    52010Everolimus.



    		+-nlClin Cancer Res 16(5):1368-72 (2010)
    62010Everolimus (RAD001) in the treatment of advanced renal cell carcinoma: a review.



    		+-nlOncologist 15(3):236-45 (2010)
    72004Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer.



    		+-nlBr J Cancer 91(8):1420-4 (2004)
    82010Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.



    		+-nlN Engl J Med 363(19):1801-11 (2010)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.